Xiaoyang Li

Xiaoyang Li practices at ChristianaCare Wilmington Hospital in Wilmington, Delaware.

Xiaoyang Li's NPI, 1679067649, was assigned on June 21, 2018. Xiaoyang Li holds Delaware license C1-0025755.

Xiaoyang Li's primary practice is ChristianaCare Wilmington Hospital, at 501 W 14th St, Wilmington, DE 19801 in New Castle County. The practice phone is (302) 733-1000.

Xiaoyang Li's primary practice is ChristianaCare Wilmington Hospital in Wilmington, Delaware. Xiaoyang Li is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Xiaoyang Li to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Xiaoyang Li practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Xiaoyang Li's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Xiaoyang Li's licenses on file in 2 states: Delaware and Minnesota.

CMS data shows 678 Medicare services from Xiaoyang Li across 7 procedure codes in 2024, for 330 Medicare patients. Medicare paid $48,118 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 330 Medicare patients who saw Xiaoyang Li in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Xiaoyang Li's median patient age at 60, with 64% women.

In 2024, Xiaoyang Li wrote 597 Medicare Part D claims for 198 patients. 89% of them were for generic drugs. CMS names the drug for 394 of them, across 14 drugs with 11 or more claims each, at $20,130 in total drug cost. In 2023, CMS named 68 claims across 3 drugs.

Xiaoyang Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Xiaoyang Li as offering telehealth.

Dmand AI links 5 papers to Xiaoyang Li, published from 2022 to 2024. 2022 was the busiest year, with 2. Xiaoyang Li's most frequent co-authors are John Jing-Wei Chen, MD, PhD, Andrew McKeon, MD and Anahit Cheluskin Mehrabyan, MD.

CMS Open Payments shows 1 general payment to Xiaoyang Li from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. TG Therapeutics, Inc. paid the most, $33.